A G Montag's research while affiliated with University of Chicago and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (65)


B.C. Toolan, P. Bolt, A.N. Clerk, H.H. Luu, Q. Kang, J.L. Kummer, Z.-L. Deng, K. Olson, F. Primus, A.G. Montag, T.-C. He, and R.C. Haydon reply
  • Article

February 2008

·

11 Reads

·

P. Bolt

·

A.N. Clerk

·

[...]

·

Share










Citations (43)


... Insulin-degrading enzyme (IDE) is a ubiquitously expressed zinc metalloendopeptidase [1]. It was initially identified as an insulin-clearing enzyme (the role for which it was named) [2]. ...

Reference:

Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa
Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues
  • Citing Article
  • February 1993

Endocrinology

... Other differential diagnostic considerations may be lymphoma, chronic osteomyelitis, osteoblastoma, and osteoid osteoma. Complications that occur predominantly in the pelvic region are osteoarthritis, fractures (proximal femur) and Paget sarcoma (usually osteosarcoma in iliac bone and proximal femur)789. ...

Sarcomas arising in Paget disease of bone, still bad after all these years: A clinicopathologic analysis of 68 cases
  • Citing Conference Paper
  • January 2006

Laboratory Investigation

... Après avoir été démontré compétiteur, CTLA-4 a été démontré inhibiteur de la réponse immunitaire (Lenschow et al., 1992(Lenschow et al., , 1993Walunas et al., 1994). Ces propos servent ainsi la pertinence d'étude et de considération des molécules CD80 et CD86, au vu de leur implication dans la régulation de la réponse immunitaire. ...

Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA41g
  • Citing Article
  • January 1992

Science

... E-cadherin overexpression is a positive prognostic factor in the clinical course of endometrioid endometrial cancer [117]. High E-cadherin expression is associated with reduced mortality, disease progression, and rate of disease recurrence [118]. ...

Prognostic significance of decreased E-cadherin protein expression in pathologic stage I - III endometrial cancer: an immunohistochemical analysis
  • Citing Article
  • October 2003

International Journal of Radiation Oncology*Biology*Physics

... Current-day treatment of ABC advocated by many is curettage with or without bone graft. To augment this procedure, high-speed burr has been described by one study done by Gibbs et al., [20] where 40 patients showed nearly 90% control rate after a median 7.2-year follow-up, following curettage, without the use of phenol, liquid nitrogen, or any other adjuvant. Burr works by mechanical disruption of the lesion to the level of the bone circumscribing the lesion. ...

Aneurysmal Bone Cyst of the Extremities: Factors Related to Local Recurrence After Curettage with a High-Speed Burr*
  • Citing Article
  • Full-text available
  • December 1999

The Journal of Bone and Joint Surgery

... There is also a model of spontaneous EAN in non-obese diabetic (NOD) mice that are deficient in the co-stimulatory B7-2 molecule (154). In this model there is inflammation and demyelination of peripheral nerves, with a chronic course. ...

Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice
Journal of Experimental Medicine (JEM)

Journal of Experimental Medicine (JEM)

... Based on this approach, a new wave of immunotherapieshas surfaced. One of the pioneering ones includes the generation of a chimeric CTLA-4-Ig protein, which is responsible for blocking co-stimulation through CD28 (Lenschow et al. 1992). Potent activation of TCR signalling cascade is highly dependent on the interaction of CD28 on T cells and its ligands, CD80 or CD86 on APCs. ...

Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
  • Citing Article
  • September 1992

Science

... Both are ligands for programmed death-1 (PD-1), which is expressed on activated T and B cells [4][5][6]. PD-L1 has been described to be inducibly expressed in a variety of organs [3,[7][8][9][10][11][12][13]]. An overwhelming number of studies supported the role of PD-L1 as a negative regulator of T cell responses and suggest that PD-L1 promotes peripheral tolerance [14]. ...

Induction of tolerance to autoimmune diabetes with islet antigens
Journal of Experimental Medicine (JEM)

Journal of Experimental Medicine (JEM)

... A recent study by Brouwers et al. demonstrated a novel molecular mechanism of one of the most extensively studied proprotein convertases (PCs), furin, in regulating glucose levels in β-cells [29]. PCs are proteolytic enzymes that are ubiquitously involved in many biological processes and play crucial roles in regulating metabolic diseases [30,31]. In their study, they showed that the absence of furin-mediated mTORC1 activation led to β-cell dysfunction (Figure 2 bottom panel) [29]. ...

Proinsulin Processing by the Subtilisin-Related Proprotein Convertases Furin, PC2, and PC3
  • Citing Article
  • October 1992

Proceedings of the National Academy of Sciences